Related Experiment Video

Updated: Jul 3, 2026

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy
07:45

Tear-Derived Exosomal miR-15a as New Diagnostic Tool for Diabetic Retinopathy

Published on: December 30, 2025

Role of microRNAs in diabetes

Xiaoqing Tang1, Guiliang Tang, Sabire Ozcan

  • 1Department of Molecular and Cellular Biochemistry, University of Kentucky, College of Medicine, 741 South Limestone, Lexington, KY 40536, USA. xiaoqing.tang@uky.edu

Biochimica Et Biophysica Acta
|July 29, 2008
PubMed

Insights

MicroRNAs (miRNAs) are newly identified regulators in diabetes pathogenesis. This review explores their role in insulin regulation and diabetes complications, offering insights into disease mechanisms.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Genetics

Background:

  • Diabetes mellitus, encompassing type 1 and type 2, is a prevalent global chronic disease.
  • Complex genetic and physiological factors contribute to diabetes, yet underlying pathogenic mechanisms require further elucidation.
  • MicroRNAs (miRNAs), small non-coding RNAs, have emerged as critical regulators in biological processes.

Purpose of the Study:

  • To review recent advancements in understanding the role of miRNAs in diabetes pathogenesis.
  • To summarize the involvement of miRNAs in regulating insulin production, secretion, and action.
  • To discuss the implications of miRNAs in diabetes-associated complications.

Main Methods:

  • Literature review of current research on miRNAs and diabetes.
  • Analysis of studies investigating miRNA function in insulin metabolism.
  • Synthesis of findings related to miRNA involvement in diabetic complications.

Main Results:

  • MiRNAs play a significant role in modulating insulin production and secretion.
  • MiRNAs are implicated in regulating insulin sensitivity and action.
  • Evidence suggests miRNAs are involved in the development of diabetes-related complications.

Conclusions:

  • MiRNAs represent a novel class of molecules crucial to diabetes pathogenesis.
  • Targeting miRNAs may offer potential therapeutic strategies for diabetes and its complications.
  • Further research into miRNA mechanisms is essential for advancing diabetes treatment.

More Related Videos

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues12:21

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues

Published on: November 30, 2013

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization08:22

Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization

Published on: September 15, 2018

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.